Reliable Data You Can Trust
Reliable Data You Can Trust
A recent
report published by Infinium Global Research on the head and neck cancer
diagnostics market provides an in-depth analysis of segments and sub-segments in
the global as well as regional head and neck cancer diagnostics market. The
study also highlights the impact of drivers, restraints, and macro indicators on
the global and regional head and neck cancer diagnostics market over the short
term as well as long term. The report is a comprehensive presentation of
trends, forecasts, and dollar values of the global head and neck cancer
diagnostics market. According to the report, the global head and neck cancer
diagnostics market is projected to grow at a CAGR of 11% over the forecast
period of 2022-2028.
The value of
the head and neck cancer diagnostics market in 2021 was USD 1.6 billion and is expected to reach USD 3 billion
in 2028 and is expected be growing with a CAGR of more than 11%. Many tests are
used by doctors to detect or diagnose cancer. They also do tests to see whether
cancer has spread to another place of the body from where it began. It's known
as metastasis when this happens. A biopsy is the only guaranteed way for a
doctor to know if a part of the body contains cancer in most types of cancer.
If a biopsy is not possible, the doctor may recommend further tests to aid in
the diagnosis. Head and neck cancer is diagnosed using a variety of assays. If
someone has symptoms and signs of head and neck cancer, the doctor will take go
check the medical history of the patient, including all risk factors and
symptoms. For the diagnosis of head and neck cancer, a variety of diagnostic
instruments along with tests are used.
The COVID-19
pandemic has most likely harmed the most vulnerable people and those who
require immediate access to healthcare, such as cancer patients. Nationally and
locally imposed restrictions, guidelines for patient management during
different pandemic waves, changes in health-seeking behavior, and the
perception that hospitals are high-risk areas for COVID-19 transmission risk
are all probably to have contributed to the observed decreases in newly
diagnosed cancer cases during the covid-19 pandemic. COVID-19 is expected to
cause diagnostic delays and an increase in advanced head and neck cancer (HNC).
COVID-19 has thus resulted in a decrease in cancer patient referral, diagnosis,
and treatment all across the world, negatively impacting the market. The increasing geriatric patient population
especially patients suffering from head and neck cancer, advancements in
treatment modes, and advanced diagnostic technologies are considered the prime
factors driving the growth of this market. Moreover, unfavorable government
regulations regarding new research, high costs associated with the treatment
modes, and lack of awareness among the people about head and neck cancer are
the key restraining factors in this market. Furthermore, a rise in the chronic
diseases among the aging population, a rise in the healthcare expenditure of
people, and better healthcare initiatives from government and private
organizations are anticipated to create more opportunities for the growth of
this market during the forecast period. Nevertheless, the low adoption rate of
digital technology-based systems and untapped markets are considered to be the
challenges faced by the global head and neck cancer diagnostics market. New
technological innovation in diagnostics is expected to offer new opportunities.
Geographically,
North America is expected to be the dominating region in the market over the
forecast period. Asia-Pacific is expected to be the fastest-growing region in
the market. The rising aging population with chronic disease, with head and
neck cancer-related, and highly developed healthcare infrastructure are
considered to be the key factors for the growth of this market region.
Moreover, Asia Pacific is expected to be the most prominent and faster-growing
market due to the presence of emerging economies such as India, China, and
Indonesia. Asia Pacific is anticipated to grow at the highest CAGR rate over
the forecast period and provides more opportunities due to increasing demand
for developed healthcare infrastructure, rising expenditure of patient
population, and rising cases of head and neck cancer in the region
The report
on the global head and neck cancer diagnostics market covers segments such as
diagnostic methods and end-user. On the basis of diagnostic methods, the
sub-markets include diagnostic imaging, endoscopy screening, bioscopy
screening, blood tests, dental diagnostic, and others. On the basis of
end-user, the sub-markets include hospitals, diagnostic centers, and others.
The report
provides profiles of the companies in the market such as Siemens AG, Identafi,
GE Healthcare, Philips Healthcare, Addent, Inc., Varian Medical Systems,
Neusoft, Toshiba, Fujifilm Holdings, and Hitachi Medical.
The report
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of the head and neck cancer diagnostics
market. Moreover, the study highlights current market trends and provides
forecasts for 2022-2028. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.
Please Choose One of them.